PEREGRINE CAPITAL MANAGEMENT LLC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 764529
MINNEAPOLIS, MN
Position in TRVI
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$6,328,280
-$27,936 QoQ
Shares Held
530,451
+4.5% QoQ
Ownership
0.374%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 37.21022299891979.ToString("F0")%
Shared 0.ToString("F0")%
None 62.78977700108022.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $94,824,642 across 14 Biotechnology names. TRVI ranks #9 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
143,136 | $8,323,358 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
146,923 | $8,299,680 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
47,296 | $7,993,969 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
201,959 | $7,773,401 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
306,272 | $7,215,768 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
146,606 | $7,207,150 | |
| 7 | CYTK |
Cytokinetics Inc
|
103,626 | $6,829,989 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
208,672 | $6,573,168 |
All Filings in TRVI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,328,280 | 530,451 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $6,356,216 | 507,685 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,677,245 | 620,464 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||